![OIS Podcast | Ophthalmology's leading Podcast artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts113/v4/80/ef/57/80ef571d-253f-a38f-8ac9-f6f65170a9a1/mza_6721181271736941586.jpg/100x100bb.jpg)
Oyster Point Pharma CEO Jeffrey Nau Highlights Details of the Company’s Recent B Round, Ponders IPO
OIS Podcast | Ophthalmology's leading Podcast
English - April 10, 2019 04:00 - 31 minutes - 14.6 MB - ★★★★★ - 30 ratingsInvesting Business Health & Fitness ophthalmology investment venture capital entrepreneurs oftalmólogo ophthalmic key opinion leader seco ascrs aao Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
With more than $100 million raised in venture capital and three late-stage clinical programs, Oyster Point Pharma is getting a lot done in a short amount of time. In this podcast, CEO and president Jeffrey Nau reveals how the company is working so quickly and ponders what the next major milestone might be.